GL261 - Toxic gain function and Loss of function, SB28 - loss of function
Glioblastoma / Brain Tumors
Genotype
GL261, SB28
Mechanism
GL261 - Toxic gain function and Loss of function, SB28 - loss of function
Phenotype
Cognitive impairment, Motor coordination, Locomotor activity, Seizures, Weakness
Biomarker
GFAP, IL 6, Nestin, S100β
Gene Expression Markers
EGFR, mTOR , KI67/CCND1, MMP2, VEGF, IL-6/TNF-α, CD133, SOX2
Physiology Changes
Intracranial tumor growth, BBB disruption, Edema
Histology Grading Endpoint
Hypercellularity, Diffuse infiltration into brain parenchyma, Microvascular proliferation, Necrosis



